Cargando…
Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with a multi-faceted pathogenesis. So far, the therapeutic paradigm “one-compound-one-target” has failed and despite enormous efforts to elucidate the pathophysiology of AD, the disease is still incurable. The multiple factors involved...
Autores principales: | Dias, Kris Simone Tranches, Viegas, Jr, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023454/ https://www.ncbi.nlm.nih.gov/pubmed/24851088 http://dx.doi.org/10.2174/1570159X1203140511153200 |
Ejemplares similares
-
Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases
por: Gontijo, Vanessa Silva, et al.
Publicado: (2020) -
Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
por: Makhoba, Xolani H, et al.
Publicado: (2020) -
Sustainable Drug
Discovery of Multi-Target-Directed
Ligands for Alzheimer’s Disease
por: Rossi, Michele, et al.
Publicado: (2021) -
PQM130, a Novel Feruloyl–Donepezil Hybrid Compound, Effectively Ameliorates the Cognitive Impairments and Pathology in a Mouse Model of Alzheimer’s Disease
por: Morroni, Fabiana, et al.
Publicado: (2019) -
Designing multi-target-directed flavonoids: a strategic approach to Alzheimer's disease
por: Park, Seongmin, et al.
Publicado: (2023)